Treatment for HER2-Positive Breast Cancer
Learn about the latest HER2-positive breast cancer treatments, including targeted therapies, monoclonal antibodies, and innovative drug options.

Liver cancer is the most prevalent type of cancer in Thailand. Most liver cancer patients seek medical advice when the disease has already worsened and is in the final stage. In most cases, the detected malignant tumor is often too large to be surgically removed. Currently, a more promising treatment for liver cancer known as Transarterial Chemoembolisation (TACE) is available.
Clear causes of liver cancer are still unknown. However, the disease is primarily associated with any of these factors:
The best treatment among various methods is to remove the tumor surgically. However, most patients have limitations that make surgery impossible, such as old age, liver cirrhosis, or tumors in multiple locations. Hence, Transarterial Chemoembolization (TACE) has become increasingly popular. The procedure is done by administrating chemotherapy directly through the artery to treat the cancerous tumor in the liver.
TACE delivers chemotherapy precisely to specific areas in the body. A catheter is inserted into an artery in the groin and threaded up to the liver. Then, the chemotherapy drug is injected directly into the blood vessels that feed the tumor and block the blood vessels with gel foam made of small gelatin to prevent blood from flowing back to the cancerous tumor. This will eventually cause the tumor to shrink and die.
The amount of chemotherapy administered is low compared to intravenous chemotherapy. Therefore, side effects of chemotherapy in other parts of the body are reduced.
Nevertheless, some remaining cancer cells may reaccumulate themselves by stimulating the surrounding healthy cells to build new blood vessels to supply blood to the tumor. Hence, TACE may need to be done every 4-6 weeks. If the tumor is large or present in multiple areas, Transarterial Chemoembolization can be done to eliminate the remaining cancer cells.